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ABSTRACT  
Thiadiazole and their derivatives have been studied colossally because of their wide range of biological activity. They are found to be effectual as 
antibacterial, antimalarial, antiviral, antiinflammatory, anticancer and antianthelminthic agents. Distinct biological activities, such as antibacterial, anti-
inflammatory, and antiviral have been consort with 1, 3, 4-thiadiazole derivatives. The substituted 1, 3, 4 Thiadiazole nucleus is particularly ubiquitous, 
and found in some marketed drugs such as acetazolamide, Methazolamide and antibacterial such as Sulphamethazole, antibiotic like Cefazoline. The 
synthesis of 1, 3, 4 Thiadiazole derivatives has allured widespread attention due to their diverse biological activities, including antimicrobial, anti-
inflammatory, analgesic, and antianthelmintic. These reviews focused on various biological activities consorted with thiadiazole nucleus. 
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INTRODUCTION 
Mostly five membered aromatic systems having three heteroatoms 
at symmetrical position have been studied because of their 
physiological properties [1]. Thiadiazole is a 5-membered ring 
system containing two nitrogen and one sulphur atom. They occur in 
nature in four isomeric forms viz. 1, 2, 3-thiadiazole; 1, 2, 5-
thiadiazole; 1, 2, 4-thiadiazole and 1, 3, 4-thiadiazole [2]. Thiadiazole 
contains the five-membered diunsaturated ring structure having 
molecular structure formula C2H3N2
The incorporation of oxygen, nitrogen, and sulfur donor atoms in the 
macrocycles markedly affect their complexing properties because of 
the hard (O, N) and soft (S) character of the donor atoms and the 
exodentate tendency of the sulfide linkages [4]. During recent years 
there has been intense investigation of different classes of 
thiadiazole compounds, many of which known to possess interesting 
biological properties such as antimicrobial [5]
S containing two carbon atoms, 
three hydrogen, two nitrogen and one sulphur [3].  
 antituberculosis, 
anticonvulsants, anti-inflammatory, antihypertensive6antioxidant, 
human adenosine A3 antagonist7
Chemistry of thiadiazole 
, anticancer [8, 9] and antifungal 
activity [10]. Thiadiazole play a prominent role in nature. For 
example, the thiazolium ring present in vitamin B1 serves as an 
electron sink and its coenzyme form is important for the 
decarboxylation of α-keto acids [11]. 
Thiadiazoles and their derivatives can be considered as simple five 
membered heterocycles possessing one sulhur and two nitrogen atoms. 
The thiadiazoles exist in different isomeric forms such as1, 2, 4-, 1, 2, 5-, 





The fig. 1 represents π-excessive ring system as the two adjacent N 
atoms of the ring carry a lone pair of electrons each. Actually 1, 3, 4-
thiadiazole molecule does not display a true aromatic behavior as do 
benzene, pyridine and thiophene. Bak et al. have made analysis of 
microwave spectra of this molecule and calculated bond lengths, 
bond angles and bond orders [13]. They concluded that the aromatic 
character as measured by the π-electron delocalization decreases in 
the order of 1, 2, 5-thiadiazole>thiophene>thiazole>1, 3, 4-
thiadiazole [14]. 1, 3, 4-thiadiazole core skeletons are subjected to 
various substitution reactions with alkyl halides, acid chlorides, and 
sulfonyl chlorides to afford various drug like 2-amino-substituted 1, 
3, 4-thiadiazole derivatives [15]. 
Tautomerism 
2-Hydroxy-1, 3, 4-thiadiazole, 2-mercapto-1, 3, 4-thiadiazole and 2-
amino thiadiazole have been reported to exist in the tautomeric 











Spectral properties of thiadiazoles 
IR spectra provide sufficient findings about the chemical structure of 
the compounds. All the synthesized compounds are characterized by 
their IR and NMR Spectra. According to Mahendrasinh et al the IR 
peaks of 2, 5 di substituted thiadiazole derivatives are perceived at 
750 (C-S str), 1333 (C-N str), 1670 (C=N str), 1630 (N-N str). [17]S. 
K. Srivastava evaluated structure 2-(2-Chloroacetyl)-mercapto-5-
methyl-1, 3, 4-thiadiazole by 1HNMR that revealed singlet of three 
methyl protons at 2. 42 (s, 3H,-CH3) and singlet of two methylene 
protons at 4. 40(s, 2H,-CH2
 














Structure activity relationship 
Structure-activity studies showed that optimum activity resulted 
when the thiadiazole ring was substituted with a 2-methylphenyl 
group and a guanidine moiety and analogues were found to lower 
blood pressure in meta corticoid (DOCA) hypertensive rats. 
[19]Christopher B. Chapleo et al stated that the unsubstituted 
guanidine was found to possess potent anticonvulsant properties; 
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considerable reduction or loss of activity however was observed 














Marketed drugs containing thiadiazole nucleus [21] (fig. 5) 
 
 
Synthetic methods of thiadiazoles 
The method commonly employed for the synthesis of 1, 3, 4-
thiadiazole is the cyclisation of thiosemicarbazide derivatives 
incorporating the basic structural unit and other method involve the 





















Ilkay Kuçukguzel synthesized the thiadiazoles from aroyl 
thiosemicarbazide and this is prepared by reacting benzoyl chloride 




















Conc. H2SO4  
Scheme 1 
 



























From isothiocyanate and hydrazine 
Sevim Rollas et al synthesized the 1, 3, 4 thiadiazoles from 
Benzocaine and Benzoyl chloride and the intermediate ethyl 4-
(benzoylamino)benzoate was added with hydrazine hydrate, which 
was then refluxed with isothiocyanate and then neutralized to get 
the final product, where R may be methyl, ethyl, propyl, 4-
methylphenyl, 4-methoxyphenyl [24]. (Scheme 3) 
From the reaction of hydrazine and carbon disulfide 
Sadaf J. Gilani gives the another method for synthesizing 1, 3, 
4thiadiazoles is by reacting dithiocarbazinate with 99% 
hydrazine hydrate to give the 4-amino-5-(pyridin-4-yl)-4H-1, 2, 
4-triazole-3-thiol and triazole is converted into thiadiazoles, by 
condensation with aromatic acids in the presence of POCl 3. 
Seung-Ju Yang et al gave a regioselective, reagent-based method for 
the cyclization reaction of 2-amino-1, 3, 4-thiadiazole in which 
thiosemicarbazide intermediate was reacted with p-TsCl, 
triethylamine in N-methyl-2-pyrrolidone to give the corresponding 
2-amino-1, 3, 4-thiadiazoles through regioselcective cyclization 
processes, where R
[25](Scheme 4) 
1is 4-methoxy-Ph and R2 is 4-NO2-Ph. [26] 
(Scheme 5) 
Mehta et al. 



























































R = a) C6H5; (b) R = 2-C6H4Cl; (c) R = 2, 4-C6H3Cl2; (d) R = 2-C6H4CH3
(e) R = 2-C
;  
6H4OCOCH3; (f) R = OC6H5 
















































Biological activities associated with thiadiazoles 
Anti-inflammatory activity 
S. Maddila et al (2012) reported a new series of 1, 3, 4-thiadiazole 
with pyrazole-3-carboxamides and pyrrole-3-carboxamide and 
seven compounds were found to exhibit significant anti-
inflammatory activity with inhibition in paw edema compared to the 
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R= C6H5, 4-NO2-C6H4,  












Mohd. Amir et al (2008) synthesized a series of 3, 6-disubstituted-1, 
2, 4-triazolo-[3, 4-b]-1, 3, 4-thiadiazoles by condensation of 4-
amino-5-substituted-3-mercapto-(4H)-1, 2, 4-triazoles with various 
substituted aromatic acids and aryl/alkyl isothiocyanates through a 
one-pot reaction. These compounds were investigated for their anti-
inflammatory, analgesic, ulcergenic, lipid peroxidation, antibacterial 
and antifungal activities and found to be more active than their 













Mohamed A. A. Radwan (2007) reported the synthesis of new 
substituted hydrazones, 1, 3, 4-thiadiazole derivatives as anti-
inflammatory agents. The 3-substituted indole derivatives played a 
very important role as anti-inflammatory and analgesic agents and 













Kamal M. Dawood (2006) reported the new series of derivatives of 
pyrazole and 1, 3, 4 thiadiazole. The newly synthesized compounds 
were found to possess anticonvulsant and anti-inflammatory 
activities with the same mechanism of action of selective COX-2 


























Substituents R Ar 
A CH3 C6H5 
B CH3 4-MeC6H4 
C CH3 4-ClC6H4 
D OC2H5 C6H5 
E OC2H5 4-MeC6H4 
F OC2H5 4-ClC6H4 
 
Silvia Schenone et al (2006) synthesized the two series of N-[5-oxo-
4-(arylsulfonyl)-4, 5-dihydro-1, 3, 4-thiadiazol-2-yl]-amides and 
evaluated for in vivo analgesic and anti-inflammatory activities. All 
the new compounds possess good analgesic action in the acetic acid 
writhing test and some compounds also showed fair anti-
inflammatory activity in the carrageenan rat paw edema test. [31] 













Compound R R1 Compound 2 R R1 2 
A H Phenyl l CH3 4-methyl phenyl 
B H 4-methyl phenyl m CH3 4-methoxy phenyl 
C H 4-methoxy phenyl n CH3 4-chloro phenyl 
D H 4-chloro phenyl o CH3 4-Fluorophenyl 
E H 4-fluoro phenyl p CH3 Fuorophenyl 
F H 2-fluoro phenyl q CH3 3-Fluorophenyl 
G H 3-fluoro phenyl r CH3 2, 4-Difluorophenyl 
h 
 
H 2, 4di fluoro phenyl s CH3 4-Trifluoromethylphenyl 
I H 4di fluoro phenyl 
methyl 
t CH3 2-Furoyl 
J H 4-furoyl    
K CH3 Phenyl    
 
Antimicrobial activity 
Kuldipsinh P. Barot et al (2013) synthesized a series of novel 1, 3, 4-
thiadiazole; 1, 2, 4-triazole-5-thione and 1, 3-thiazolan-4-one 
derivatives of benzimidazole were synthesized by nucleophilic 
substitution reaction of 2-substituted-1[H] benzimidazole and these 
compounds were evaluated by spectral and elemental methods of 
analysis for antibacterial and antifungal activities. [32](fig. 11).  
Tomasz Plech et al (2012) synthesized eight derivatives of 1, 2, 4-
triazolo [3, 4-b]1, 3, 4-thiadiazole and evaluated for their in vitro 
antimicrobial activity. Compounds with different substitutents as 
listed in table indicated high activity towards Gram-positive 
bacteria, which were up to 16 times more than currently used 
antibiotics.  
The influence of an aryl fragment at position C-3 of the 1, 2, 4-
triazolo [3, 4-b] 1, 3, 4-thiadiazole system, seems the most 
beneficial for the anti-MSSA and anti-MRSA activity is the presence 
of chlorine atom at the meta position of the phenyl ring. [33] (fig. 
12) (table. 4) 
Mehta et al. 





















compound R R1 2 
A H -Cl 
B H -Br 
C 2-Cl -Cl 
D 2-Cl -Br 
E 3-Cl -Cl 
F 3-Cl -Br 
G 4-Cl -Cl 
H 4-Cl -Br 
Amandeep Kaur(2012) reported the synthesis of some novel 
heterocyclic derivatives comprising imidazole and 1, 3, 4-thiadiazole 
containing biphenyl moiety. Structures of the compounds were 
elucidated by spectral studies and evaluated for antibacterial 
activity against various strains of Escherichia coli, Pseudomonas 
aeruginosa and Bacillus subtilis, and antifungal activity against 
Candida albicans, Saccharomyces cerevisiae and Aspergillus niger. 










Mahendrasinh M. Raj et al (2011) synthesized the Morpholine, 
Phthalimide and Piperidene derivatives of 1, 3, 4-Thiadiazole. The 
chemical structures of the synthesized compounds were confirmed 
by means of IR, 1
These compounds were screened for antibacterial such as 
Staphylococcus aureusATCC 9144, Becillus Cereus ATCC 11778, 
Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 
2853 and anti-fungal Aspergillus niger ATCC 9029 and 
Aspergillus fumigates ATCC 46645 by paper disc diffusion 
technique [35]. (fig. 14) 



















Arvind k. singh et al (2011) reported the synthesis of 2, 5-
Disubstituted 1, 3, 4-thiadiazoles and evaluated for various 
pharmacological activities such as antibacterial, anti-inflammatory 









Abdul R. Bhat et al (2011) synthesized a new series of thiadiazoles 
and intermediate thiosemicarbazones from the chloroquinone 
molecule and evaluated the compounds for their in vitro anti-
microbial activity was performed against Staphylococcus aureus, 
Streptococcus pyogenes, Salmonella typhimurium, and Escherichia 













X=H, Cl, CH3 
S. Nanjunda Swamy (2006) synthesized the two series of 4, 6-
disubstituted 1, 2, 4-triazolo-1, 3, 4-thiadiazole derivatives and were 
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checked for their efficacy as antimicrobials in vitro. Compounds 
showed significant inhibition against all the strains of Bacillus 
subtilis, Escherichia coli, Pseudomonas fluorescens, Xanthomonas 
campestris,  Xanthomonas oryzae, when compared to standard drugs. 














S. Talath and A. K. Gadada (2006) synthesized a series of 7-[4-(5-
amino-1, 3, 4 thiadiazole-2-sulfonyl)]-1-piperazinyl fluoroquinolonic 
derivatives and characterized by IR, 1H-NMR, 13
 
C NMR, FAB Mass 
spectral and elemental analyses. The compounds were evaluated for 
their preliminary in vitro antibacterial activity against some Gram-
positive and Gram-negative bacteria and selected compounds were 
screened for antitubercular activity against Mycobacterium 


















Hai-Chuan Zhao et al (2013) represented a novel series of 1, 3-
selenazole-containing 1, 3, 4-thiadiazole derivatives bearing Schiff 
base moieties and evaluate for their in vitro antiproliferative 
activities against human breast cancer cell MCF-7 and mouse 










Negar Mohammadhosseini et al (2013) synthesized a new series of 
1-(substituted benzyl)-4-(5-(5-nitroaryl-2-yl)-1, 3, 4-thiadiazol-2-yl) 
piperazine derivatives and the most potent nitrofuran derivative 
containing 3-methoxybenzyl piperazine pendant at the C-2 position 
















Omaima M. Abdelhafez et al (2012) synthesized the new series of 4-
methyl and 3, 4-dimethyl-7-oxycoumarin derivatives of thiadiazoles 
and evaluated for their monoamine oxidase (MAO) A and B 
inhibiting effect. The docking experiments carried out on MAO-A and 
MAO-B structures proved new information about the 
enzyme−inhibitor interaction and the potential therapeutic 



















C. Lopez-Cara (2012) synthesized the new compounds of 1, 3, 4-
thiadiazole structure, and there in vitro biological evaluation as 
inhibitors of both neuronal and inducible Nitric Oxide Synthase 
(nNOS and iNOS) is done. These compounds have been designed by 
an isosteric modification of a series of 4, 5-dihydro-1H-pyrazole 
derivatives, previously described as the nNOS inhibitors.  
Docking studies conclude that the stronger interaction between the 
inhibitor and the enzyme is the reinforced hydrogen bond formed 
between the guanidinium moiety of the inhibitor and Glu592 (Glu371 in 
iNOS) carboxylate. The insertion of the S atom in the heterocyclic ring 
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Xin Jian Song (2011) et al synthesized novel fluorinated pyrazolo 
[3, 4-d] pyrimidine derivatives containing 1, 3, 4-thiadiazole. Their 
antitumor activities were evaluated against HL-60 by an MTT assay. 
The preliminary results indicated that some title compounds exhibit 
more potent antitumor inhibitory activity than doxorubicin (DOX). 














Rahmi Kasmo gullar (2010) synthesized a new series of Pyrazole 
carboxylic acid derivatives of 5-amino-1, 3, 4-thiadiazole-2-
sulfonamide from ethyl 3-(chlorocarbonyl)-1-(3-nitrophenyl)-5-
phenyl-1H-pyrazole-4-carboxylate and studied the in vitro 
inhibitory effects on hydratase and esterase activities of carbonic 
anhydrase isoenzymes (HCA-I and HCA-II). [45] (fig. 24) 
D. A. Ibrahimre presented (2009)a new series of 3, 6-disubstituted 
triazolo [3,4-b] thiadiazole derivatives and evaluated for their 
cytotoxic activity against a panel of 60 human cancer cell lines by the 
National Cancer Institute (NCI) and some of them demonstrated 
inhibitory effects on the growth of a wide range of cancer cell lines 


































































Mohammad Yusuf et al (2008) synthesized a number of new imine derivatives of 5-amino-1, 3, 4-thiadiazole-2-thiol. Two compounds namely 5-{[1-
(4-chlorophenyl)-3-(4-methoxy-phenyl)prop-2-en-1-ylidene]-amino}-5-benzylthio-1, 3, 4 –thiadiazole and 5-{[1-(4-chlorophenyl)-3-(4-dimethyl-
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R1= H, OCH3, (CH3)2N, Cl, OH, R2= H, Cl 
Nalan Terzioglu and Aysel Gursoy (2003) synthesized some novel 2, 6-dimethyl-N-substituted phenylmethylene-imidazo[2, 1-b][1, 3, 4]thiadiazole-
5-carbohydrazides derivatives from 2, 6-dimethylimidazo-[2, 1-b][1, 3, 4]thiadiazole-5-carbohydrazide. The newly synthesized compounds were 

























Stephen Turner et al (1988) synthesized a series of 2-aryl-5-guanidino-(or N-substituted guanidino)-1, 3, 4-thiadiazoleas and closely related 
analogues were found to lower blood pressure in meta corticoid (DOCA) hypertensive rats, in the 2-methylphenyl series, the iminoimidazolidine 
was of comparable activity to that of the unsubstituted guanidine. The iminoimidazolidine showed a somewhat longer duration of actionthan the 
guanidine derivatives. Preliminary studies in a pithed rat preparation indicated that these thiadiazole derivatives lowered blood pressure by a 
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